Cargando…

Strategy to Better Select HIV-Infected Individuals for Latent TB Treatment in BCG-Vaccinated Population

OBJECTIVE: To evaluate the T-SPOT.TB interferon-γ releasing assay and the tuberculin skin test (TST), for the diagnosis of latent tuberculosis infection(LTBI) and the development of subsequent active tuberculosis, in BCG-vaccinated HIV-infected individuals. METHODS: HIV-infected individuals without...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chin-Hui, Chan, Pei-Chun, Liao, Say-Tsung, Cheng, Shu-Hsing, Wong, Wing-Wai, Huang, Li-Min, Hsueh, Po-Ren, Chiou, Hung-Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754919/ https://www.ncbi.nlm.nih.gov/pubmed/24015285 http://dx.doi.org/10.1371/journal.pone.0073069

Ejemplares similares

Commentary: Bettering BCG: a tough task for a TB vaccine?
por: Srivastava, Brahm S., et al.
Publicado: (2019)

A longitudinal study on latent TB infection screening and its association with TB incidence in HIV patients
por: Wong, Ngai Sze, et al.
Publicado: (2019)

Protective Effect of BCG and Neutrophil-to-Lymphocyte Ratio on Latent Tuberculosis in End Stage Renal Disease
por: Wang, Ping-Huai, et al.
Publicado: (2023)

Vaccination with BCGΔBCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG
por: Aceves-Sánchez, Michel de Jesús, et al.
Publicado: (2021)

The diversity of latent TB
por: Young, Douglas
Publicado: (2010)

Separating latent and acute TB
por: Doherty, T Mark
Publicado: (2010)

Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCGΔBCG1419c
por: Gunasena, Manuja, et al.
Publicado: (2022)

The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study
por: Yang, Chin-Hui, et al.
Publicado: (2014)

Performance of QuantiFERON-TB Gold In-Tube test and Tuberculin Skin Test for diagnosis of latent tuberculosis infection in BCG vaccinated health care workers
por: Babayigit, Cenk, et al.
Publicado: (2014)

Epidemiology of TB in prisoners: a metanalysis of the prevalence of active and latent TB
por: Placeres, Aline Ferreira, et al.
Publicado: (2023)

Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations
por: Pooransingh, Shalini, et al.
Publicado: (2020)

TB infection and BCG vaccination: are we protected from COVID-19?
por: Madan, M., et al.
Publicado: (2020)

Effect of diabetes mellitus on risk of latent TB infection in a high TB incidence area: a community-based study in Taiwan
por: Kuo, Shu-Chen, et al.
Publicado: (2019)

Interferon Gamma Release Assays for the Diagnosis of Latent TB Infection in HIV-Infected Individuals in a Low TB Burden Country
por: Ní Cheallaigh, Clíona, et al.
Publicado: (2013)

Host factors influencing the activation of tuberculosis in HIV positive individuals with latent TB infection
por: Devalraju, Kamakshi Prudhula, et al.
Publicado: (2014)

Neonatal BCG vaccination and child survival in TB-exposed and TB-unexposed children: a prospective cohort study
por: Thysen, Sanne M, et al.
Publicado: (2020)

Latent Tuberculosis Infection Testing Strategies for HIV-Positive Individuals in Hong Kong
por: Wong, Ngai Sze, et al.
Publicado: (2019)

Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2009)

Combination of Cytokine Responses Indicative of Latent TB and Active TB in Malawian Adults
por: Hur, Yun-Gyoung, et al.
Publicado: (2013)

Serological analysis reveals differential antibody responses between TB patients and latently infected individuals from the TB endemic country of Mozambique
por: Tran, Andy C., et al.
Publicado: (2023)

‘Fight TB with BCG’: Mass Vaccination Campaigns in the British Caribbean, 1951–6
por: Altink, Henrice
Publicado: (2014)

761. Age-Related Incidence of TB Infection Supporting Efficacy of BCG Vaccination
por: Sweeney, Eileen, et al.
Publicado: (2018)

Imaging characteristics of pulmonary BCG/TB infection in patients with chronic granulomatous disease
por: Yao, Qiong, et al.
Publicado: (2022)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2011)

Age-related waning of immune responses to BCG in healthy children supports the need for a booster dose of BCG in TB endemic countries
por: Whittaker, Elizabeth, et al.
Publicado: (2018)

Screening and identification of a six-cytokine biosignature for detecting TB infection and discriminating active from latent TB
por: Wang, Sen, et al.
Publicado: (2018)

Molecular Evidence for Intra- and Inter-Farm Spread of Porcine mcr-1-Carrying Escherichia coli in Taiwan
por: Hsueh, Shun-Chung, et al.
Publicado: (2020)

Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice
por: Hu, Zhidong, et al.
Publicado: (2017)

Latent Transition Analysis of Motor Development Patterns in Preschoolers
por: Chao, Hsueh-Chin, et al.
Publicado: (2023)

Multicenter Surveillance of Capsular Serotypes, Virulence Genes, and Antimicrobial Susceptibilities of Klebsiella pneumoniae Causing Bacteremia in Taiwan, 2017–2019
por: Liao, Chun-Hsing, et al.
Publicado: (2022)

Risk of latent TB infection in individuals employed in the healthcare sector in Germany: a multicentre prevalence study
por: Schablon, Anja, et al.
Publicado: (2010)

PPE17 (Rv1168c) protein of Mycobacterium tuberculosis detects individuals with latent TB infection
por: Abraham, Philip Raj, et al.
Publicado: (2018)

Pre-Clinical Development of BCG.HIVA(CAT), an Antibiotic-Free Selection Strain, for HIV-TB Pediatric Vaccine Vectored by Lysine Auxotroph of BCG
por: Saubi, Narcís, et al.
Publicado: (2012)

IV BCG Vaccination and Aerosol BCG Revaccination Induce Mycobacteria-Responsive γδ T Cells Associated with Protective Efficacy against M. tb Challenge
por: Morrison, Alexandra L., et al.
Publicado: (2023)

Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming
por: Gonçalves, Eduardo DC, et al.
Publicado: (2007)

Preclinical Development of an In Vivo BCG Challenge Model for Testing Candidate TB Vaccine Efficacy
por: Minassian, Angela M., et al.
Publicado: (2011)

Is the BCG Vaccine Safe for Undernourished Individuals?
por: Ishikawa, Larissa Lumi Watanabe, et al.
Publicado: (2012)

The use of anti-tuberculosis therapy for latent TB infection
por: Denholm, Justin T, et al.
Publicado: (2010)

Dexamethasone: Latent mycobacterium TB reactivation: case report
Publicado: (2021)

Latent TB Infection Diagnosis in Population Exposed to TB Subjects in Close and Poor Ventilated High TB Endemic Zone in India
por: Kashyap, Rajpal S., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pa48l1q78hqr9suip12ruvkagr